Compare CABO & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CABO | LAB |
|---|---|---|
| Founded | 1980 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 425.5M | 347.5M |
| IPO Year | 2015 | 2008 |
| Metric | CABO | LAB |
|---|---|---|
| Price | $36.19 | $0.92 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 1 |
| Target Price | ★ $125.67 | $1.35 |
| AVG Volume (30 Days) | 288.7K | ★ 5.1M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 61.54 |
| EPS | ★ 6.12 | 0.33 |
| Revenue | ★ $1,501,423,000.00 | $101,937,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.83 | $2.63 |
| P/E Ratio | $5.76 | ★ $2.84 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $33.38 | $0.70 |
| 52 Week High | $180.74 | $1.72 |
| Indicator | CABO | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 35.30 | 52.39 |
| Support Level | N/A | $0.90 |
| Resistance Level | $58.71 | $1.02 |
| Average True Range (ATR) | 5.21 | 0.08 |
| MACD | -0.54 | 0.02 |
| Stochastic Oscillator | 11.97 | 79.79 |
Cable One Inc is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. The company derives majority of its revenue from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.